USE OF SUBSTITUTED 1-AMINO-5-PHENYLPENTAN-3-OL AND / OR 1-AMINO-6-PHENYLHEXAN-3-OL COMPOUNDS AS A MEDICAMENT

摘要

The use of at least one substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compound and/or one of the enantiomers thereof and/or one of the diastereomers thereof and/or one of the physiologically acceptable salts thereof for producing a medicament that has an N-methyl-D-aspartate-(NMDA)-antagonistic effect.